This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LOUIS T. WRIGHT, M.D.; MILTON ROTHMAN, M.D.

AMA Arch Surg. 1951;62(1):23-28.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORTS of deaths due to hemorrhagic diatheses resulting from the use of bishydroxycoumarin U. S. P. (dicumarol) have been accumulating in the literature. Since the drug became available in 1941, overly enthusiastic reports leading to its general use prophylactically and therapeutically, coupled with the lack of adequate laboratory tests for its control, have resulted in an increased number of reported and unreported fatalities.

The recent publications of Lilly and Lee,¹ in which five deaths were recorded, as well as Duff and Shull's² résumé of 23 deaths resulting from the use of dicumarol have focused attention on this problem. One notes additional examples of fatalities such as the two deaths in Arthur Allen's³ series and one in Gross's⁴ series on vascular grafts. There are undoubtedly many more unpublished cases in smaller hospitals and in general practice.

De Takats'⁵ recent report is not in agreement with the . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Surgical Service of the Harlem Hospital, Department of Hospitals, City of New York.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?